Take a look at Medifocus MFS.V. It seems to have great potential
-Currently entering Phase III trial in a very large disease category
-Phase III criteria no more stringent than phase 2, where criteria was significantly exceeded
-38 U.S. and international patents with 18 pending
-Midpoint data release allowed by FDA
-As for the business model, the majority of revenue will be from Medifocus' disposable probes that offer 90% gross margins
-Market Cap under $7 million at $0.25 per share
BSD Medical recently got approval for a similar technology in a smaller disease category and now has a $140+ million market cap